COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,789 Articles (22,946 medRxiv, 8,843 bioRxiv)

Most recent first Previous |  Page 2093: Articles 20921-20930  | Next

The variation of genome sites associated with severe COVID-19 across populations: the worldwide and national pattern
Balanovsky, O., Petrushenko, V., Mirzaev, K., Abdullaev, S., Gorin, I., Chernevskiy, D., Agdzhoyan, A., Balanovska, E., Kryukov, A., Sychev, D.
10.1101/2020.11.22.20236414 — Posted: 2020-11-24
Use of alternative RNA storage and extraction reagents and development of a hybrid PCR-based method for SARS-CoV-2 detection
Yang, J., Salfati, E., Kao, D., Mihaylova, Y.
10.1101/2020.11.21.20236216 — Posted: 2020-11-24
Building a virtual summer research experience in cancer for high school and early undergraduate students: lessons from the COVID-19 pandemic
Corson, T. W., Hawkins, S. M., Sanders, E., Byram, J., Cruz, L.-A., Olson, J., Speidell, E., Schnabel, R., Balaji, A., Ogbeide, O., Dinh, J., Hinshaw, A., Cummings, L., Bonds, V., Nakshatri, H.
10.1101/2020.11.23.393967 — Posted: 2020-11-23
Publishing of COVID-19 Preprints in Peer-reviewed Journals, Preprinting Trends, Public Discussion and Quality Issues
Kodvanj, I., Homolak, J., Virag, D., Trkulja, V.
10.1101/2020.11.23.394577 — Posted: 2020-11-23 Discussion: Onsite | Offsite
In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1
Chaudhari, A., Chaudhari, M., Mahera, S., Saiyed, Z., Nathani, N., Shukla, S., Patel, C., Patel, D., Joshi, M., Joshi, C.
10.1101/2020.11.22.393009 — Posted: 2020-11-23
Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19
Steuten, K., Kim, H., Widen, J. C., Babin, B. M., Onguka, O., Lovell, S., Bolgi, O., Cerikan, B., Cortese, M., Muir, R. K., Bennett, J. M., Geiss-Friedlander, R., Peters, C., Bartenschlager, R., Bogyo, M.
10.1101/2020.11.21.392753 — Posted: 2020-11-23 Discussion: Onsite
Stable neutralizing antibody levels six months after mild and severe COVID-19 episode
Pradenas, E., Trinite, B., Urrea, V., Marfil, S., Avila-Nieto, C., Rodriguez de la Concepcion, M. L., Tarres-Freixas, F., Perez-Yanes, S., Rovirosa, C., Ainsua-Enrich, E., Rodon, J., Vergara-Alert, J., Sagales, J., Guallar, V., Valencia, A., Izquierdo-Useros, N., Paredes, R., Mateu, L., Chamorro, A., Massanella, M., Carrillo, J., Clotet, B., Blanco, J.
10.1101/2020.11.22.389056 — Posted: 2020-11-23
A Synthetic Defective Interfering SARS-CoV-2
Yao, S., Narayanan, A., Majowicz, S., Jose, J., Archetti, M.
10.1101/2020.11.22.393587 — Posted: 2020-11-23
The multidisciplinary nature of COVID-19 research
Arencibia-Jorge, R., Garcia-Garcia, L., Galban-Rodriguez, E., Carrillo-Calvet, H.
10.1101/2020.11.23.394312 — Posted: 2020-11-23
N439K variant in spike protein may alter the infection efficiency and antigenicity of SARS-CoV-2 based on molecular dynamics simulation
Zhou, W., Xu, C., Wang, P., Luo, M., Xu, Z., Cheng, R., Jin, X., Guo, Y., Xue, G., Juan, L., Nie, H., Jiang, Q.
10.1101/2020.11.21.392407 — Posted: 2020-11-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).